Randomised clinical trial: colestyramine vs
First approved by the FDA to manage type 2 diabetes as Ozempic, later approved at a higher dose as Wegovy specifically for chronic weight management
Frontiers in Bioscience (Landmark Edition) , 21 (7), 1314-1329
Sudip Bose Topics Key Points: Losing weight can increase the risk of muscle and bone density loss, whether a person takes a GLP-1 weight loss medication, crash diets or has weight-loss surgery
Start your intake How Tirzepatide Causes Nausea and Why Timing Matters Tirzepatide works by activating GLP-1 and GIPR receptors in the brain and gut, slowing gastric emptying and reducing appetite
This means that insulin is released when blood sugar levels are higher, reducing the risk of hypoglycaemia (low blood sugar) unless other glucose-lowering medicines are being used in conjunction with Mounjaro